Sponsor and CEO Disclose 17% Stake in Research Alliance Corp IV Post-IPO
RACD is trading near its 52-week low of $10 (4.4% above the low).
Summary
The SPAC's sponsor and CEO disclosed a 17% stake in Research Alliance Corp IV, including 275,000 private placement shares bought for $2.75 million and 1.26 million Class B shares acquired for just $25,000.
Key Events · Ownership and Investor Activity · RACD
-
Sponsor and CEO Report 17% Stake
Research Alliance Holdings IV LLC and CEO Matthew Hammond beneficially own 1,538,529 Class A ordinary shares (on an as-converted basis), representing 17.0% of the outstanding shares post-IPO.
-
Private Placement Purchase
The sponsor acquired 275,000 Class A shares at $10.00 per share for a total of $2,750,000 in a private placement concurrent with the IPO closing on July 14, 2026.
-
Founder Shares Acquired for Nominal Cost
The sponsor initially paid $25,000 for 1,014,706 Class B shares (approx. $0.02 per share) in April 2026, which increased to 1,263,529 shares after a share capitalization and transfers to directors.
-
Lock-Up and Voting Commitments
The sponsor and CEO are subject to lock-up restrictions on their shares and have agreed to vote in favor of any proposed business combination, aligning their interests with the SPAC's objectives.
Analysis · RACD · Real Estate & Construction
Research Alliance Holdings IV LLC, the SPAC's sponsor, and CEO Matthew Hammond reported a combined 17.0% ownership stake (1,538,529 shares) following the company's $75 million IPO. The filing reveals the sponsor paid $2.75 million for 275,000 private placement shares at $10.00 each, alongside 1,263,529 Class B shares acquired for a nominal $25,000. This insider alignment is typical for SPACs, but the detailed breakdown of the sponsor's low-cost founder shares and the private placement investment provides transparency on the economic incentives driving the search for a business combination.
At the time of this filing, RACD was trading at $10.44 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $95M. The 52-week trading range was $10.00 to $11.65. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.